Welcome to our dedicated page for Soren Acquisition news (Ticker: SORNU), a resource for investors and traders seeking the latest updates and insights on Soren Acquisition stock.
Soren Acquisition Corp. (SORNU) is a blank check company whose units trade on the Nasdaq Global Market. The company has publicly announced the pricing and closing of its initial public offering of units, which include Class A ordinary shares and redeemable warrants. These events mark key milestones in its formation and capital-raising process as it prepares to seek a business combination.
This news page aggregates coverage related to Soren Acquisition Corp.’s securities, offering activity, and stated business objectives. Readers can find updates on the company’s initial public offering, including details on the number of units offered, the unit price, the exercise of the underwriters’ over-allotment option, and the resulting gross proceeds as disclosed in its press releases.
Because Soren Acquisition Corp. is a blank check company focused on completing a business combination, news about the company often centers on capital markets activity, listing information on Nasdaq, and its focus on identifying an attractive target business within the healthcare industry. Announcements also highlight the structure of its units, the terms of its redeemable warrants, and the expected trading symbols for its Class A ordinary shares and warrants once they trade separately.
In addition, company news has described the roles of BTIG, LLC as sole book-running manager and various law firms as legal counsel in connection with the offering. Investors and observers can use this page to follow how Soren Acquisition Corp. communicates its progress from initial public offering through its search for a suitable business combination candidate.
Soren Acquisition Corp (Nasdaq: SORN) announced that, effective February 27, 2026, holders of units may elect to separately trade Class A ordinary shares and warrants included in the Units.
The Class A Ordinary Shares will trade as SORN, the whole warrants as SORNW, and unsplit Units will continue trading as SORNU. Each Unit contains one Class A Ordinary Share and one-third of a warrant; each whole warrant is exercisable for one share at $11.50. No fractional warrants will be issued. BTIG acted as sole book-running manager.
Soren Acquisition Corp (NASDAQ:SORN) closed an initial public offering of 25,300,000 units (including a 3,300,000-unit over-allotment) at $10.00 per unit, generating $253,000,000 in gross proceeds. Units began trading on January 7, 2026 on the Nasdaq Global Market under the symbol SORNU; once separated, Class A shares and warrants are expected to list as SORN and SORNW. Each unit comprises one Class A ordinary share and one‑third of one redeemable warrant; each whole warrant is exercisable to buy one Class A share at $11.50. The company is a blank check company focused on completing a business combination, with management led by CEO Arghavan Di Rezze and CFO Jamie Weber.
Soren Acquisition Corp (NASDAQ:SORN) priced an initial public offering of 22,000,000 units at $10.00 per unit, representing gross proceeds of $220,000,000, with trading of units expected to begin on January 7, 2026 under the ticker SORNU.
Each unit includes one Class A ordinary share and one-third of a redeemable warrant; whole warrants will trade separately as SORNW and will entitle holders to buy one share at $11.50 per share. The offering is expected to close on January 8, 2026 and the underwriters have a 45-day over-allotment option to purchase up to 3,300,000 additional units.
The company is a blank check vehicle focused on healthcare business combinations and named its management and board, with BTIG acting as sole book-running manager.